Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)
China · Delayed Price · Currency is CNY 37.60
+0.17 (0.45%)
Jan 22, 2026, 3:00 PM CST
Jiangsu Sinopep-Allsino Biopharmaceutical Company Description
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company, engages in the research and development, production, and sale of peptides, oligonucleotides, and small molecule drugs in China.
The company offers Peptide CDMO Services,GMP oligo, full-time equivalent, discovery, generic APIs, and formulation services.
It is also involved in professional technical services. The company was founded in 2009 and is headquartered in Hangzhou, China.
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.
| Country | China |
| Founded | 2009 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 2,028 |
| CEO | Ziquan Tong |
Contact Details
Address: No. 1378 Wenyi West Road Hangzhou, 311121 China | |
| Phone | 86 571 8867 1216 |
| Website | sinopep.com |
Stock Details
| Ticker Symbol | 688076 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000051X5 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Ziquan Tong | GM and Chairman |
| Wei Ding | Financial Director |
| Xiaohua Li | Senior Vice President |
| Guoqiang Shi | Senior Vice President and Director |
| Zhou Hua | Secretary of Board |
| Dr. Jianjun Jiang Ph.D. | Vice President |
| Yanwen Chen | Accounting Supervisor |